Back to calendar
Inhibikase Therapeutics, Inc. (IKT) Earnings
IKT reports earnings on Monday, August 17, 2026
earnings report
August 17, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.11
Actual EPS: $-0.10
EPS surprise: 7.69%
Company overview
Market Cap$307.6M
PriceUSD 2.33
EPS (TTM)-0.43
52-week high2.53
52-week low1.33
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees35